(株)コスモス薬品の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM小売業3349/E03446COSMOS Pharmaceutical Corporation
公表日公表担保新規貸付前週比新規借入（自己）前週比新規借入（転貸）前週比
2020/02/28日証協無担保802株0%0株0%2,614株+1144.76%
2020/02/28日証協有担保260,421株-59.64%8,045株+6717.8%39,922株+0.52%
2020/02/21日証協無担保0株-100%0株0%210株+2.94%
2020/02/21日証協有担保645,264株+32.92%118株-41%39,716株+58.47%
2020/02/14日証協無担保1,400株0%0株-100%204株-59.36%
2020/02/14日証協有担保485,457株+229.9%200株-93.33%25,062株-64.95%
2020/02/07日証協無担保0株0%400株0%502株+148.51%
2020/02/07日証協有担保147,154株+70.14%3,000株-72.73%71,511株+48.06%
2020/01/31日証協無担保0株0%0株-100%202株-98.8%
2020/01/31日証協有担保86,490株-72.74%11,000株-68.83%48,300株-69.43%
2020/01/24日証協無担保0株-100%15,800株0%16,903株+4104.73%
2020/01/24日証協有担保317,316株+82.72%35,288株+292.96%158,000株+33.45%
2020/01/17日証協無担保100株+1.01%0株0%402株-73.38%
2020/01/17日証協有担保173,660株+59.68%8,980株-51.93%118,394株+397.45%
2020/01/10日証協無担保99株-92.93%0株0%1,510株-52.83%
2020/01/10日証協有担保108,756株+749.66%18,680株+167.24%23,800株+600%
2019/12/30日証協有担保12,800株-90.46%6,990株-64.71%3,400株-94.15%
2019/12/27日証協無担保1,401株0%0株-100%3,201株-76.12%
2019/12/27日証協有担保134,135株-48.97%19,807株-22.26%58,100株+0.21%
2019/12/20日証協無担保0株0%12,900株0%13,402株+1015.9%
2019/12/20日証協有担保262,849株-62.36%25,480株+4.75%57,976株-82.03%
2019/12/13日証協無担保0株-100%0株0%1,201株-53.83%
2019/12/13日証協有担保698,315株+36.98%24,324株+8.13%322,674株+178.36%
2019/12/06日証協無担保3,600株-75.34%0株0%2,601株-92.27%
2019/12/06日証協有担保509,805株-49.83%22,496株-93.49%115,918株-26.16%
2019/11/29日証協無担保14,600株0%0株0%33,661株+31.81%
2019/11/29日証協有担保1,016,139株+16.83%345,317株+1053.25%156,976株+18.28%
2019/11/22日証協無担保0株0%0株-100%25,538株-65.28%
2019/11/22日証協有担保869,780株+122.39%29,943株+98.84%132,715株+122.49%
2019/11/15日証協無担保0株-100%12,500株0%73,557株+1238.37%
2019/11/15日証協有担保391,101株+132.96%15,059株-92.94%59,651株-75.62%
2019/11/08日証協無担保2,744株+0.37%0株0%5,496株-77.69%
2019/11/08日証協有担保167,885株-27.27%213,450株+905.51%244,673株+64.89%
2019/11/01日証協無担保2,734株0%0株0%24,637株+53.65%
2019/11/01日証協有担保230,846株-38.23%21,228株+16.73%148,382株+54.79%
2019/10/25日証協無担保0株0%0株0%16,034株+594.71%
2019/10/25日証協有担保373,736株+9.51%18,186株-41.98%95,859株+52.47%

※株式分割は考慮していませんのでご注意ください。

Page Top